Stem Cell Clinical Trials: Designing Preclinical Studies for First in Human Trials | Joy Cavagnaro

Before bringing a therapy to trials in patients, it must first be tested for safety and effectiveness in animals. Performing these pre-clinical studies for stem cell-based products present added challenges since many represent novel therapeutic approaches that have never been tried in humans. At the March 6th CIRM-hosted Staying on the Critical Path Workshop, Joy Cavagnaro, president of Access BIO, provides CIRM-funded scientists advice about optimizing these studies.

Learn about California's progress toward stem cell therapies

Disease Programs

Learn about how stem cell research could generate the therapies for many chronic diseases and injuries

See disease fact sheets

CIRM Stem Cell Blog